MD995Y - Method for treating Herpes simplex virus type 1 and 2-induced infection - Google Patents
Method for treating Herpes simplex virus type 1 and 2-induced infection Download PDFInfo
- Publication number
- MD995Y MD995Y MDS20150006A MDS20150006A MD995Y MD 995 Y MD995 Y MD 995Y MD S20150006 A MDS20150006 A MD S20150006A MD S20150006 A MDS20150006 A MD S20150006A MD 995 Y MD995 Y MD 995Y
- Authority
- MD
- Moldova
- Prior art keywords
- acyclovir
- herpes simplex
- simplex virus
- virus type
- treating herpes
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 241000700588 Human alphaherpesvirus 1 Species 0.000 title abstract 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 title abstract 2
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 229960004150 aciclovir Drugs 0.000 abstract 3
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 abstract 3
- 108010078049 Interferon alpha-2 Proteins 0.000 abstract 1
- 102000006601 Thymidine Kinase Human genes 0.000 abstract 1
- 108020004440 Thymidine kinase Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 230000035945 sensitivity Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to medicine, in particular to a method for treating Herpes simplex virus type 1 and 2-induced infection.According to the invention, the method consists in carrying out the clinical and paraclinical examination of the patient and initiation of etiotropic therapy with acyclovir, and of anti-inflammatory, sedative, analgesic, local, immunomodulatory and vitamin-therapeutic treatment, at the same time within 12…24 hours after the clinical examination is carried out the acyclovir sensitivity testing of virus strains taken from herpetic vesicles, and in case of detection of acyclovir-resistant strains, it is replaced from the second day of treatment with an antiviral drug with thymidine kinase-independent action based on human recombinant interferon α-2b.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20150006A MD995Z (en) | 2015-01-27 | 2015-01-27 | Method for treating Herpes simplex virus type 1 and 2-induced infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDS20150006A MD995Z (en) | 2015-01-27 | 2015-01-27 | Method for treating Herpes simplex virus type 1 and 2-induced infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD995Y true MD995Y (en) | 2016-01-31 |
| MD995Z MD995Z (en) | 2016-08-31 |
Family
ID=55235465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDS20150006A MD995Z (en) | 2015-01-27 | 2015-01-27 | Method for treating Herpes simplex virus type 1 and 2-induced infection |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD995Z (en) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU491387A1 (en) * | 1974-07-18 | 1975-11-15 | Всесоюзный Научно-Исследовательский Институт Лекарственных Растений | Flavonoid compounds exhibiting antiherpetic activity |
| SU1720649A1 (en) * | 1981-08-06 | 1992-03-23 | Институт Биоорганической Химии Ан Узсср | Antiherpetic remedy "megosine" |
| SU1246005A1 (en) * | 1984-07-13 | 1986-07-23 | Московский научно-исследовательский институт вирусных препаратов | Method of estimating pharmacological activity of chemical drugs for curing genital herpes |
| SU1530189A1 (en) * | 1988-04-15 | 1989-12-23 | Научно-Исследовательский Институт Эпидемиологии И Микробиологии Им.Почетного Акад.Н.Ф.Гамалеи | Method of treatment of recurring herpes simplex |
| MD1051C2 (en) * | 1996-12-02 | 1999-05-31 | Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova | Antiherpetic remedy |
| MD1473G2 (en) * | 1998-06-02 | 2001-05-31 | Национальный Научно-Практический Центр Превентивной Медицины Министерства Здравоохранения Республики Молдова | Antiherpetic remedy |
| RU2492861C1 (en) * | 2012-05-29 | 2013-09-20 | Закрытое акционерное общество "Вектор-Медика" (ЗАО "Вектор-Медика") | Method of treating recurrent genital herpes with chronic fatigue symptoms |
-
2015
- 2015-01-27 MD MDS20150006A patent/MD995Z/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MD995Z (en) | 2016-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rossignol | Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus | |
| Mehandru et al. | The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection | |
| Peng et al. | Protective effect of fluvastatin on influenza virus infection | |
| FI3865484T3 (en) | Pde9 inhibitor with imidazo pyrazinone backbone for treatment of peripheral diseases | |
| FI3377534T3 (en) | Treatment of lung cancer using a combination of an anti-pd-1 antibody and an anti-ctla-4 antibody | |
| Xu et al. | Tetrandrine suppresses β-glucan-induced macrophage activation via inhibiting NF-κB, ERK and STAT3 signaling pathways | |
| UY36099A (en) | LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH MULTIPLE RECURRENT MULTIPLE SCLEROSIS (RRMS) WITH A HIGH DEGREE OF DISABILITY | |
| Matcham et al. | Comment on: The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis: reply | |
| Karateev et al. | Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial | |
| RU2014117294A (en) | 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE | |
| Trivedi et al. | A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis | |
| Jeong et al. | A case of severe HIV-associated psoriasis successfully treated with acitretin therapy | |
| RU2008113615A (en) | METHOD FOR TREATING INFECTIONS CAUSED BY FIRST AND SECOND TYPES SIMPLE VIRUS, CYTOMEGALOVIRUS, EPSTEIN-BARR VIRUS | |
| Swart et al. | OP0217 Adjudication of infections in the pharmacovigilance in juvenile idiopathic arthritis patients (pharmachild) treated with biologic agents and/or methotrexate | |
| Neves | Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 | |
| Erfanian et al. | Treatment of COVID-19 patients using plasma therapy: Letter to Editor | |
| Kalyuzhin et al. | Clinical and interferon-modulating efficacy of a combination of rectal and topical dosage forms of interferon-α2b in acute respiratory infections | |
| Kolev et al. | GLYCYRRHIZINIC ACID--AN ALTERNATIVE METHOD FOR TREATMENT OF CONDYLOMATA ACUMINATA | |
| Pinzone et al. | Comment about “Lymphomas and other cancers in HIV-infected patients” | |
| Yasue Ishii-Osai et al. | Infliximab treatmenteinduced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction | |
| Popov | Questionnaire of pharmacy visitors and doctors about the use of soft dosage form drugs | |
| Nakamura | Pure red cell aplasia: case report | |
| Bowles et al. | Resilience hardiness and family support in severely injured service members and their spouses | |
| Karadag | Symmetrical drug related intertriginous and flexural exanthema: case report | |
| Mekseepralard et al. | PP239—Susceptibility of leptospira to xanthones and synergistic effects with antibiotics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG9Y | Short term patent issued | ||
| MK4Y | Short term patent expired |